Tianjin Keyken Technology

Tianjin Keyken Technology is a biotechnology company focused on the development of innovative transdermal drug delivery systems, specifically soluble microneedle technology. The company's platform utilizes biocompatible and biodegradable polymer materials to encapsulate drugs, allowing for painless penetration of the skin's stratum corneum and subsequent controlled release. Keyken's research and development efforts target a wide range of applications, including the delivery of insulin for diabetes, vaccines for infectious diseases, and active ingredients for medical aesthetics. By providing a needle-free alternative to traditional injections, the company aims to enhance patient compliance and eliminate the need for cold-chain logistics for certain biologics. Keyken operates out of Tianjin, China, and maintains strong ties with academic research institutions to drive its technological advancements.